PRESS RELEASE: University Confers Academic Appointments On Key Viapath Leaders
London, UK, 8 July 2015: King’s College London has announced academic appointments for two members of the Viapath leadership team. Dr Jonathan Edgeworth, Viapath Medical Director, has been made Professor of Clinical Infectious Diseases and Dr Dominic Harrington, Viapath Scientific Director has been made Reader in Clinical Haematology. In both cases the awards are in recognition of their outstanding academic achievements.
In recent years, Dr Edgeworth's research group has been evaluating rapid molecular diagnostics to reduce healthcare associated infections and ensure appropriate antibiotic use. This research has been conducted in the Centre for Clinical Infection & Diagnostics Research (CIDR), which is adjacent to the Viapath Infection diagnostic laboratories at St Thomas' Hospital. This award therefore exemplifies one of Viapath's important objectives, which is to integrate academic and laboratory diagnostic service excellence.
Dr Harrington’s primary research interests have been to develop and apply novel laboratory markers for the assessment of vitamin status. To support this, in 2002 he coined the word ‘Nutristasis’ and set up the Human Nutristasis Unit at St Thomas’ Hospital. The unit has grown from a single staff member to a dedicated group of 12 with an annual activity of approaching 300,000 tests. Dr Harrington’s view is that laboratory tests routinely used to determine vitamin status are frequently too insensitive to detect patients who would benefit from nutritional support.
Commenting on the appointments, Richard Jones, Viapath Chief Executive, said: “I am delighted that King’s College London has recognised the outstanding academic achievements by Jonathan and Dominic. We are very lucky to have leaders in Viapath who are also playing a role in extending knowledge in the broader field of medical science for the benefit of patients and who combine exceptional clinical and academic skills with being extremely effective senior managers. These appointments bring credit to the whole organisation and are an inspiration to the emerging generation of scientists in Viapath.”
About Viapath
Viapath was created in 2009 by public and private sector investors and is now the fastest growing and most successful company of its kind in the UK. It is majority owned by two leading NHS Foundation Trusts – Guy's & St Thomas' and Kings College Hospital, with its minority private sector owner Serco, bringing an additional source of investment and commercial capability. The management team at Viapath offers a mix of NHS and commercial expertise, with clinical and scientific leaders central to both strategy and day-to-day delivery.
A scientific organisation with a clinical purpose, Viapath's core values lie in Innovation, Expertise and Collaboration while its service philosophy delivers:
High Quality Service: The highest standards of scientific, clinical and operational delivery
Added Value: Clinical interpretation integral to the service, rooted in the patient pathway - and
Efficiency: Getting it right first time; a well-managed process of delivery
For more information visit synnovis.co.uk
